Unichem gets USFDA nod for hypertension drug

0
171

Drug maker Unichem Laboratories today said it has received approval from the US health regulator to market Valsartan tablets, a hypertension drug. The company has received approval from the US Food and Drug Administration (USFDA) to market the product, Unichem Laboratories said in a regulatory filing.

LEAVE A REPLY